Infliximab and Biosimilar Yield Similar Results in IBD : vim

New data supported the safety and efficacy of nonmedical switching from infliximab to a biosimilar, according to researchers.

Related Keywords

Canada , United Kingdom , Vancouver , British Columbia , Canadian , British , Thomas Tam Hoang , Laura Targownik , University Of Toronto Temerty Faculty Medicine , Centre Of British Columbia , Journal Of The Canadian Association Gastroenterology , Health Canada , University Of British Columbia Faculty Medicine , British Columbia Faculty , Medscape Medical , Canadian Association , Medscape Medical News , Mount Sinai Hospital , Temerty Faculty , Inflammatory Bowel Disease Ibd , Biologic Therapy , Iologics , Biosimilars , Biosimilar Drugs , Follow On Biologics , Board Certification , Boards , Oard Recertification , Crohn 039s Disease , Crohn Disease , Egional Enteritis Crohn S , Ulcerative Colitis , Lcerative Colitis Uc , C Ulcerative Colitis , Colitis , Computed Tomography , It , Ct Scan , Grant , Anti Tnf ,